FDA Approves 'Temp Pee Hole' Gadget for Enlarged Prostate Relief
Published Date: 5/29/2025
Rule
Summary
The FDA is officially classifying a new device that helps with urinary problems caused by an enlarged prostate as a Class II device with special safety rules. This means the device will be safer and easier to get for patients who need it. The change helps companies bring this helpful device to market faster without extra red tape.
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
Device Classified as Class II — Safer Access
The FDA classified the temporarily-placed urethral opening system for symptoms of benign prostatic hyperplasia as a Class II device with special controls. The FDA says this classification provides a reasonable assurance of safety and effectiveness and will enhance patients' access by reducing regulatory burdens, making the device easier to get for patients who need it.
Lower Regulatory Burden for Manufacturers
By classifying this temporarily-placed urethral opening system as Class II with special controls, the FDA says regulatory burdens will be reduced. The change is intended to help companies bring this device to market faster without extra red tape.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in